Skip to main content

Peer Review reports

From: Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial

Original Submission
8 Nov 2022 Submitted Original manuscript
14 Apr 2023 Reviewed Reviewer Report - Manan Karki
3 May 2023 Reviewed Reviewer Report - Research Square Reviewer 1
1 Jun 2023 Author responded Author comments - Maryam Hafizi
Resubmission - Version 2
1 Jun 2023 Submitted Manuscript version 2
21 Jun 2023 Reviewed Reviewer Report - Research Square Reviewer 1
24 Jun 2023 Reviewed Reviewer Report - Manan Karki
6 Jul 2023 Author responded Author comments - Maryam Hafizi
Resubmission - Version 3
6 Jul 2023 Submitted Manuscript version 3
8 Aug 2023 Author responded Author comments - Maryam Hafizi
Resubmission - Version 4
8 Aug 2023 Submitted Manuscript version 4
Publishing
5 Sep 2023 Editorially accepted
11 Nov 2023 Article published 10.1186/s13063-023-07624-2

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215